UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000046892
Receipt number R000053503
Scientific Title Randomized controlled trial for evaluation of behavior change by peer support type habituation app for people who are actively supported by specific health guidance(PEER-App Study)
Date of disclosure of the study information 2022/02/14
Last modified on 2023/08/31 16:07:53

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Randomized controlled trial for evaluation of behavior change by peer support type habituation app for people who are actively supported by specific health guidance(PEER-App Study)

Acronym

Randomized controlled trial for evaluation of behavior change by peer support type habituation app for people who are actively supported by specific health guidance(PEER-App Study)

Scientific Title

Randomized controlled trial for evaluation of behavior change by peer support type habituation app for people who are actively supported by specific health guidance(PEER-App Study)

Scientific Title:Acronym

Randomized controlled trial for evaluation of behavior change by peer support type habituation app for people who are actively supported by specific health guidance(PEER-App Study)

Region

Japan


Condition

Condition

None

Classification by specialty

Medicine in general

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to evaluate the effect of peer-supported habit-forming application on behavioral change toward lifestyle habits when it is used in addition to health guidance for those who fall under the category of active support for specific health guidance.

Basic objectives2

Others

Basic objectives -Others

At the beginning of the study, each individual will set a target number of steps to be taken each day, which will be achieved on a continuous basis. Participants will be randomly divided into two groups, one using the habit-forming app and the other not using the app, and changes in weight and lifestyle habits after three months and changes in health checkup data after one year will be compared.
The group using the habit-forming app will be challenged to achieve their individual goals by a team. For the non-use group, there is no team and they work alone to achieve their goals. For the group using the habit-forming app, the digital peer support of the habit-forming app will encourage behavioral change in health.

Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Amount and rate of weight change after 3 months

Key secondary outcomes

After 3 months:.
BMI change, change in abdominal circumference, change in body composition, change in steps from baseline, change in average steps per 2 weeks over time, change in self-efficacy (questionnaire for healthy people), change in lifestyle as assessed by standard questionnaire

After 1 year
Changes in physical examination values, changes in lifestyle habits as assessed by the standard questionnaire, changes in health guidance stratification judgment, changes in the percentage of people with metabolic syndrome, changes in the percentage of people who start medication for lifestyle-related diseases


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification

YES

Dynamic allocation

YES

Institution consideration

Institution is not considered as adjustment factor.

Blocking

YES

Concealment

No need to know


Intervention

No. of arms

2

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Behavior,custom

Interventions/Control_1

Using the Habituation App, you can know the number of steps you take every day, and challenge each person to achieve their goals in groups of five. Once a day about the results, post the number of steps + photos to your team and share information with each other.

Interventions/Control_2

Using the Steps app, you can know the number of steps you take every day, but don't have a team, work on your own goals. No posting or sharing of information will be done.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

40 years-old <=

Age-upper limit

64 years-old >=

Gender

Male and Female

Key inclusion criteria

1 Must have fallen under the category of "active support" in the specific health checkup in FY2021
2 Must be between the ages of 40 and 64
3 Use a smartphone on a daily basis
4 Those who have received sufficient explanation and given written consent of their own free will to participate in this study.

Key exclusion criteria

1 Those who have used the "Habit-forming Application (Minchare)" used in this study within the past 6 months
2 Heart disease, serious hepatic disorder, renal disorder, or malignant tumor (recurrence-free period of less than 5 years)
3. Patients with complications of infectious diseases
4 Those who have pacemakers or other internal devices installed.
5 Others who are deemed inappropriate by the research leader or co-worker

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Yasuhiro
Middle name
Last name Nishizaki

Organization

Tokai University School of Medicine

Division name

Department of Clinical Health Science

Zip code

259-1193

Address

143 Shimokasuya, Isehara, Kanagawa 259-1193, Japan

TEL

0463-93-1121

Email

y-nishizaki@tokai.ac.jp


Public contact

Name of contact person

1st name Takashige
Middle name
Last name Oroguchi

Organization

Tokai University School of Medicine

Division name

Lifecare Center Graduate School of Medicine

Zip code

259-1193

Address

143 Shimokasuya, Isehara, Kanagawa 259-1193, Japan

TEL

0463-93-1121

Homepage URL


Email

oroguchi@is.icc.u-tokai.ac.jp


Sponsor or person

Institute

Tokai University

Institute

Department

Personal name



Funding Source

Organization

A10 Lab Inc.

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Institutional Review Board for Clinical Research, Tokai University Hospital

Address

143 Shimokasuya, Isehara, Kanagawa 259-1193, Japan

Tel

0463-93-1121

Email

tokai-rinsho@ml.tokai-u.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 02 Month 14 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

88

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2021 Year 07 Month 15 Day

Date of IRB

2021 Year 09 Month 07 Day

Anticipated trial start date

2021 Year 09 Month 13 Day

Last follow-up date

2022 Year 12 Month 31 Day

Date of closure to data entry

2023 Year 03 Month 20 Day

Date trial data considered complete

2023 Year 03 Month 20 Day

Date analysis concluded

2023 Year 03 Month 20 Day


Other

Other related information



Management information

Registered date

2022 Year 02 Month 12 Day

Last modified on

2023 Year 08 Month 31 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000053503